Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.

Fonseca C, Soiffer R, Ho V, Vanneman M, Jinushi M, Ritz J, Neuberg D, Stone R, DeAngelo D, Dranoff G.

Blood. 2009 Feb 19;113(8):1681-8. doi: 10.1182/blood-2007-09-114157. Epub 2008 Nov 13.

PMID:
19008459
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.

Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.

J Immunother. 2001 May-Jun;24(3):205-11.

PMID:
11394497
[PubMed - indexed for MEDLINE]
3.

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.

Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF.

Cancer Chemother Pharmacol. 2000;46 Suppl:S67-72.

PMID:
10950151
[PubMed - indexed for MEDLINE]
4.

Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.

Cancer Res. 2001 Nov 1;61(21):7925-33.

PMID:
11691814
[PubMed - indexed for MEDLINE]
Free Article
5.

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.

Hodi FS, Schmollinger JC, Soiffer RJ, Salgia R, Lynch T, Ritz J, Alyea EP, Yang J, Neuberg D, Mihm M, Dranoff G.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6919-24. Epub 2002 Apr 30.

PMID:
11983866
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.

Inoue H, Iga M, Nabeta H, Yokoo T, Suehiro Y, Okano S, Inoue M, Kinoh H, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K.

Cancer Sci. 2008 Nov;99(11):2315-26. doi: 10.1111/j.1349-7006.2008.00964.x. Epub 2008 Oct 18.

PMID:
18957055
[PubMed - indexed for MEDLINE]
8.

Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.

Jinushi M, Hodi FS, Dranoff G.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9190-5. Epub 2006 Jun 5.

PMID:
16754847
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.

Zhou X, Jun DY, Thomas AM, Huang X, Huang LQ, Mautner J, Mo W, Robbins PF, Pardoll DM, Jaffee EM.

Cancer Res. 2005 Feb 1;65(3):1079-88.

PMID:
15705910
[PubMed - indexed for MEDLINE]
Free Article
10.

Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.

Jinushi M, Hodi FS, Dranoff G.

Immunol Rev. 2008 Apr;222:287-98. doi: 10.1111/j.1600-065X.2008.00618.x. Review.

PMID:
18364009
[PubMed - indexed for MEDLINE]
11.

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH Jr, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF.

Cancer Res. 1997 Apr 15;57(8):1537-46.

PMID:
9108457
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targets of protective tumor immunity.

Dranoff G.

Ann N Y Acad Sci. 2009 Sep;1174:74-80. doi: 10.1111/j.1749-6632.2009.04938.x. Review.

PMID:
19769739
[PubMed - indexed for MEDLINE]
13.

Enhancing whole-tumor cell vaccination by engaging innate immune system through NY-ESO-1/dendritic cell interactions.

Xu L, Zheng J, Nguyen DH, Luong QT, Zeng G.

J Immunother. 2013 Oct;36(8):412-22. doi: 10.1097/CJI.0b013e3182a80263.

PMID:
23994888
[PubMed - indexed for MEDLINE]
14.

Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.

Driessens G, Hoffmann P, Pouwels M, Zlotta A, Schulman C, Velu T, Bruyns CA.

J Immunother. 2009 Feb-Mar;32(2):140-4. doi: 10.1097/CJI.0b013e3181920275.

PMID:
19238012
[PubMed - indexed for MEDLINE]
15.

Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.

Ho VT, Vanneman M, Kim H, Sasada T, Kang YJ, Pasek M, Cutler C, Koreth J, Alyea E, Sarantopoulos S, Antin JH, Ritz J, Canning C, Kutok J, Mihm MC, Dranoff G, Soiffer R.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15825-30. doi: 10.1073/pnas.0908358106. Epub 2009 Aug 26.

PMID:
19717467
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.

Chang EY, Chen CH, Ji H, Wang TL, Hung K, Lee BP, Huang AY, Kurman RJ, Pardoll DM, Wu T.

Int J Cancer. 2000 Jun 1;86(5):725-30.

PMID:
10797297
[PubMed - indexed for MEDLINE]
17.

Active immunotherapy induces antibody responses that target tumor angiogenesis.

Schoenfeld J, Jinushi M, Nakazaki Y, Wiener D, Park J, Soiffer R, Neuberg D, Mihm M, Hodi FS, Dranoff G.

Cancer Res. 2010 Dec 15;70(24):10150-60. doi: 10.1158/0008-5472.CAN-10-1852.

PMID:
21159637
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.

Hodi FS, Butler M, Oble DA, Seiden MV, Haluska FG, Kruse A, Macrae S, Nelson M, Canning C, Lowy I, Korman A, Lautz D, Russell S, Jaklitsch MT, Ramaiya N, Chen TC, Neuberg D, Allison JP, Mihm MC, Dranoff G.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3005-10. doi: 10.1073/pnas.0712237105. Epub 2008 Feb 19.

PMID:
18287062
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.

Kojima T, Yamazaki K, Tamura Y, Ogura S, Tani K, Konishi J, Shinagawa N, Kinoshita I, Hizawa N, Yamaguchi E, Dosaka-Akita H, Nishimura M.

Hum Gene Ther. 2003 May 20;14(8):715-28.

PMID:
12804136
[PubMed - indexed for MEDLINE]
20.

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.

Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV, Davis T, Henry-Spires R, MacRae S, Willman A, Padera R, Jaklitsch MT, Shankar S, Chen TC, Korman A, Allison JP, Dranoff G.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4712-7. Epub 2003 Apr 7.

PMID:
12682289
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk